Overview
Trine Horsbol practices practicing medicine in Copenhagen, Denmark.
Her clinical expertise encompasses Breast Cancer, Cervical Cancer, Anal Cancer, and Hodgkin Lymphoma.
She is actively involved in clinical research, co-authoring 33 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Trine A. Horsbol
Is Trine A. Horsbol a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Trine A. Horsbol is classified as an Experienced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Trine A. Horsbol participate in research or clinical trials?
Yes. Trine A. Horsbol has published 33 articles and abstracts on conditions like Breast Cancer. You can view a list of Trine A. Horsbol's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anal CancerMs. Horsbol isExperienced. Learn about Anal Cancer.
- Breast CancerMs. Horsbol isExperienced. Learn about Breast Cancer.
- Cervical CancerMs. Horsbol isExperienced. Learn about Cervical Cancer.
- Hodgkin LymphomaMs. Horsbol isExperienced. Learn about Hodgkin Lymphoma.